Retour
24
Fourchette du Jour
39,82 €
41,03 €
Fourchette 52 Semaines
38,13 €
57,82 €
Volume
1 860 378
Moyenne 50J / 200J
48,45 €
/
47,37 €
Clôture Précédente
39,78 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 19,7 | 0,3 |
| P/B | 2,2 | 3,0 |
| ROE % | 11,6 | 3,7 |
| Net Margin % | 20,3 | 3,8 |
| Rev Growth 5Y % | -1,9 | 10,0 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Hold
54,33 €
+33.7%
Low: 50,00 €
High: 59,00 €
P/E Prévisionnel
16,15
BPA Prévisionnel
2,52 €
Croissance BPA (est.)
+0,0%
CA Est.
2,22B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
3,54 €
3,51 € – 3,59 €
|
2,77B | 2 |
| FY2029 |
3,27 €
3,25 € – 3,32 €
|
2,63B | 2 |
| FY2028 |
3,02 €
2,74 € – 3,66 €
|
2,49B | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-20 | N/A | 0,52 € | — |
| 2025-11-04 | 0,61 € | 0,64 € | +4,9% |
| 2025-08-05 | 0,60 € | 0,60 € | 0,0% |
| 2025-05-07 | 0,50 € | 0,55 € | +9,3% |
| 2025-02-05 | 0,60 € | 0,61 € | +1,7% |
| 2024-11-06 | 0,54 € | 0,57 € | +5,6% |
| 2024-07-31 | 0,53 € | 0,57 € | +7,5% |
| 2024-04-29 | 0,44 € | 0,46 € | +4,5% |
Dividend History
2 yr streakYield
0,01%
Payout Ratio
0,13%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jan 08, 2026 | — | 2,41 € | 5,49% |
| Jul 02, 2025 | Jul 10, 2025 | 0,25 € | 3,18% |
| Jan 29, 2025 | — | 1,26 € | 2,96% |
| Jan 30, 2024 | Jan 31, 2024 | 1,28 € | 3,19% |
| Jan 25, 2017 | Jan 25, 2017 | 1,08 € | 4,12% |
| Dec 27, 2002 | — | 0,03 € | 0,56% |
Points Clés
Revenue declined -1,85% annually over 5 years
Earnings grew 408,28% over the past year
ROE of 11,57% — decent returns on equity
Net margin of 20,33% shows strong profitability
Debt/Equity of 0,44 — conservative balance sheet
Generating 453,28M in free cash flow
Croissance
Revenue Growth (5Y)
-1,85%
Revenue (1Y)5,65%
Earnings (1Y)408,28%
FCF Growth (3Y)23,61%
Qualité
Return on Equity
11,57%
ROIC7,18%
Net Margin20,33%
Op. Margin24,90%
Sécurité
Debt / Equity
0,44
Current Ratio3,90
Interest Coverage15,65
Valorisation
P/E Ratio
19,71
Forward P/E16,15
P/B Ratio2,22
EV/EBITDA17,66
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,65% | Revenue Growth (3Y) | 3,12% |
| Earnings Growth (1Y) | 408,28% | Earnings Growth (3Y) | 11,57% |
| Revenue Growth (5Y) | -1,85% | Earnings Growth (5Y) | -4,58% |
| Profitability | |||
| Revenue (TTM) | 2,09B | Net Income (TTM) | 424,88M |
| ROE | 11,57% | ROA | 6,75% |
| Gross Margin | 61,79% | Operating Margin | 24,90% |
| Net Margin | 20,33% | Free Cash Flow (TTM) | 453,28M |
| ROIC | 7,18% | FCF Growth (3Y) | 23,61% |
| Safety | |||
| Debt / Equity | 0,44 | Current Ratio | 3,90 |
| Interest Coverage | 15,65 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,13% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 2 yrs | ||
| Valuation | |||
| P/E Ratio | 19,71 | Forward P/E | 16,15 |
| P/B Ratio | 2,22 | P/S Ratio | 4,01 |
| PEG Ratio | 0,05 | Forward PEG | N/A |
| EV/EBITDA | 17,66 | Fwd EV/EBITDA | 12,63 |
| Forward P/S | 3,78 | Fwd Earnings Yield | 6,19% |
| FCF Yield | 5,41% | ||
| Market Cap | 8,37B | Enterprise Value | 9,19B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,09B | 1,98B | 1,97B | 2,14B | 2,25B |
| Net Income | 424,88M | 83,59M | 341,30M | 423,21M | 512,60M |
| EPS (Diluted) | 2,04 | 0,38 | 1,65 | 2,05 | 2,47 |
| Gross Profit | 1,29B | 967,35M | 1,23B | 1,38B | 1,45B |
| Operating Income | 520,31M | 97,71M | 409,94M | 531,46M | 630,08M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,30B | 5,69B | 6,12B | 6,29B | 6,15B |
| Total Liabilities | 2,52B | 2,12B | 2,31B | 2,82B | 3,05B |
| Shareholders' Equity | 3,78B | 3,57B | 3,81B | 3,47B | 3,10B |
| Total Debt | 1,65B | 1,61B | 1,69B | 2,03B | 2,12B |
| Cash & Equivalents | 839,01M | 663,56M | 668,08M | 730,67M | 880,52M |
| Current Assets | 2,00B | 1,96B | 2,15B | 2,39B | 2,11B |
| Current Liabilities | 512,14M | 543,63M | 1,08B | 974,52M | 1,52B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#930 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026